-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

603.P1.49 603. Lymphoid Oncogenesis: Basic: Poster I

Symposia: Lymphoid Oncogenesis: Basic Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Aishwarya Gurumurthy*, Ashwin Iyer*, Rohan Kodgule, MD, MBBS*, Athalee Aguilar*, Travis Saari*, Juhi Gupta*, Cody Hall, MS*, John S. Runge, PhD*, Matthew Weiss*, Marcin P. Cieslik, PhD* and Russell J. H. Ryan, MD

Department of Pathology, University of Michigan Medical School, Ann Arbor, MI

Kashi Raj Bhattarai, PhD1,2*, Kelly R. Barnett, PhD1,2*, Robert J. Mobley, PhD3,4*, Daniel C. Ferguson, PhD1,2*, Jonathan D. Diedrich, PhD1,4*, Brennan P. Bergeron, MS1,2,5*, Wenjian Yang, PhD1,2*, Kristine R. Crews, PharmD1,2*, Wendy Stock, MD6, Elisabeth Paietta, PhD7*, Steven M. Kornblau, MD8, Hiroto Inaba, MD, PhD1,9, Sima Jeha, MD1,9, Ching-Hon Pui, MD1,10, Cheng Cheng, PhD11*, Mary V. Relling, PharmD1,2, William E. Evans, PharmD1,2, Jun J. J. Yang, PhD1,4,5,12 and Daniel Savic, PhD1,2,5,12

1Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN
2Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
3Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children’s Research Hospital, Memphis, TN
4Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN
5Graduate School of Biomedical Sciences, St. Jude Children's Research Hospital, Memphis, TN
6Comprehensive Cancer Center, University of Chicago Medicine, Chicago, IL
7Albert Einstein College of Medicine, New York, NY
8Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
10Department of Oncology, St. Jude Children's Rsch./Hosp., Memphis, TN
11Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
12Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN

Sarah Spoeck*, Nadine Kinz*, Andreas Villunger* and Verena Labi, PhD*

Medical University of Innsbruck, Innsbruck, Austria

Andrew Takeda*, Jaewoong Lee, PhD*, Tim Wartewig, MD, PhD, Alberto Bigogno*, David Fonseca Arce* and Markus Müschen, MD

Center of Molecular and Cellular Oncology and Department of Immunobiology, Yale University, New Haven, CT

Gisele Olinto Libanio Rodrigues, PhD1*, Wenqing Li, PhD1*, Julie Hixon2*, Hila Winer, PhD1*, Tu Chun Hsu, DVM3*, Timothy Gower3*, Sarah Cramer, DVM, PhD4*, Caroline Andrews, MVD, PhD5* and Scott Durum, PhD1*

1National Cancer Institute, National Institutes of Health, Frederick, MD
2Cytokines and Immunity Section, Center for Cancer Research, National Cancer Institute, Frederick
3NIH, Frederick
4StageBio, Frederick
5Charles River Laboratories, Frederick

Kentaro Yamaguchi, MD1,2*, Junji Koya, MD, PhD1*, Kota Mizuno, MD1,2*, Kota Yoshifuji, MD, PhD1*, Yuta Ito1,3*, Mitsuhiro Yuasa, MD1,4*, Yuki Saito, MD, PhD1,5*, Mariko Tabata, MD1,6*, Sumito Shingaki, MD, PhD1*, Yasunori Kogure, MD, PhD1*, Kazutaka Nakashima, MD7*, Koichi Ohshima, MD, PhD7* and Keisuke Kataoka, MD, PhD1,2

1Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan
2Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
3Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
4Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
5Department of Gastroenterology, Keio University School of Medicine, Tokyo, Japan
6Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
7Department of Pathology, Kurume University School of Medicine, Kurume, Japan

Rafael Renatino-Canevarolo, PhD1*, Mark B. Meads, PhD2*, Maria L. Coelho Siqueira Silva, MSc1*, Praneeth Reddy Sudalagunta, PhD1*, Christopher Cubitt, PhD3*, Gabriel De Avila, BS4*, Raghunandan Reddy Alugubelli, MS2*, Amit Kulkarni, PhD5*, Qi Zhang, PhD5*, Oliver Hampton, PhD5*, Rachid C. Baz, MD6, Kenneth H. Shain, MD, PhD2 and Ariosto Siqueira Silva, PhD1*

1Department of Cancer Physiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
2Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
3Cancer PK/PD Core, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
4Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
5M2GEN, Tampa, FL
6Department of Malignant Hematology, Moffitt cancer center and research institute, tampa, FL

Alasdair Duguid1*, Camille Malouf1*, Vasiliki Symeonidou1*, Christina Halsey2 and Katrin Ottersbach1*

1Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
2Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom

Sankalp Srivastava, MS1*, Jie Jiang, PhD2*, Gretchen Seim3*, Jagannath Misra, PhD4*, Utpal Dave, MD5, Reuben Kapur, PhD1, Jiehao Zhou, MD2*, Jing Fan, PhD3*, Ronald Wek, PhD4* and Ji Zhang, PhD1

1Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN
2Indiana University, Indianapolis, IN
3Morgridge Institute for Research, University of Wisconsin-Madison, Madison, WI
4Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN
5Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN

Moritz Bewarder, MD1*, Michelle Elbert1*, Konstantinos Christofyllakis, MD1*, Kristina Heyne, Ph.D.1*, Gabi Carbon1*, Natalie Fadle1*, Evi Regitz1*, Maximilian Kiefer, MD1*, Igor Age Kos, MD1*, Joerg Thomas Bittenbring, MD1*, Frank Neumann, Ph.D.1*, Falko Fend, MD2*, Irina Bonzheim, Ph.D.2* and Lorenz Thurner, MD1

1Department of Hematology, Oncology, Rheumatology and Clinical Immunology, Saarland University Medical Center, Homburg, Germany
2Department of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany

Sonia Debek, MSc, BA1,2*, Dorota Komar, PhD2,3*, Filip Garbicz1,4*, Aleksandra Matrejek, MSc2*, Michał Pawlak, PhD2*, Ewa Jabłońska, PhD2*, Maciej Szydlowski, PhD2*, Magdalena Skrzypczak, PhD2*, Sylwia Radomska, MSc5*, Daniela Bellarosa, PhD6*, Nazli Serin, MSc7*, Malgorzata Bajor, PhD8,9*, Bjoern Chapuy, MD, PhD10,11 and Przemyslaw Juszczynski, MD, PhD2*

1Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland
2Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
3Centre for Omic Sciences (COS), Eurecat, Centre Tecnològic de Catalunya, Reus, Spain
4Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Warszawa, Mazowieckie, Poland
5Department of Molecular Biology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
6Experimental and Translational Oncology Department, Menarini Ricerche S.p.A., Pomezia (rome), AL, Italy
7Department of Hematology and Medical Oncology, University of Medical Center Göttingen, Göttingen, Germany
8Department of Clinical Immunology, Medical University of Warsaw, Warsaw, Poland
9Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland
10Department of Hematology, Oncology and Tumor Immunology, Charité University Medical Center Berlin, Berlin, Germany
11Department of Hematology and Medical Oncology, University of Medical Center Göttingen, Goettingen, Germany

Joana R Costa, PhD1*, David O'Connor, MD2,3*, Nurkaiyisah Anuar, MSc4*, Sunniyat Rahman, PhD MBiochem1,5*, Nivedita Singh, PhD6*, Zhaodong China, PhD7*, Tanya Rapoz-D’Silva, BSc, MSc1*, Yang Li, PhD1*, Kent Fung, PhD1*, Sara Hyseni1*, Stephen Henderson, PhD8*, George Morrow9*, Yanping Guo, DPhil9*, Javier Herrero, PhD8*, Richard Jenner, PhD10*, Dennis Keppei, Ph.D.4*, A. Thomas Look, MD7 and Marc R. Mansour, MD1,11,12*

1UCL Cancer Institute, Department of Haematology, University College London, London, United Kingdom
2Department of Haematology, Great Ormond Street Hospital for Children, London, United Kingdom
3UCL Cancer Institute, Department of Haematology, University College London, London, ENG, United Kingdom
4Cancer Science Institute of Singapore, Singapore, Singapore
5Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia
6Laboratory for Molecular Cell Biology (LMCB), University College London, London, United Kingdom
7Dana-Farber Cancer Institute, Department of Pediatric Oncology, Harvard Medical School, Boston, MA
8Cancer Institute, Bill Lyons Informatics Centre, University College London, London, United Kingdom
9UCL Cancer Institute, Flow Cytometry Translational Technology Platform, University College London, London, United Kingdom
10UCL Cancer Institute, Department of Cancer Biology, University College London, London, United Kingdom
11University College London Hospitals NHS Foundation Trust, London, United Kingdom
12Great Ormond Street Institute of Child Health, University College London, London, ENG, United Kingdom

Taylor J Chen, BS1*, Cory Seth Bridges, BS2*, Monica Puppi, M.S.2* and Daniel Lacorazza, PhD3

1Texas Children’s Hospital Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX
2Texas Children’s Hospital. Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX
3Texas Children’s Hospital, Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX

Evan Healy, PhD1,2*, Rachel McCole, PhD1*, Craig Monger, PhD1*, James Nolan3,4*, Eric Conway, PhD1*, Gerard Brien, PhD1*, Cheng Wang, PhD1*, Hannah K Neikes5*, Frances Potjewyd, PhD6*, Michiel Vermeulen, PhD7*, Aoibhinn Mooney8*, Richard Flavin, MD, PhD, FRCPath9*, Elisabeth Vandenberghe, MD, PhD3, Lindsey I James, PhD10* and Adrian P Bracken, PhD1*

1Trinity College Dublin, Smurfit Institute of Genetics, Dublin, Ireland
2Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Clayton, Victoria, Australia
3St James' Hospital, Department of Haematology, Dublin, Ireland
4Trinity College Dublin, Smurfit Institute of Genetics, Limeirck, Ireland
5Faculty of Science, Radboud Institute for Molecular Life Sciences, Department of Molecular Biology, Nijmegen, Netherlands
6UNC Eshelman School of Pharmacy, Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Chapel Hill, NC
7Radboud Institute for Molecular Life Sciences, Oncode Institute, Department of Molecular Biology, Faculty of Science, Nijmegen, Netherlands
8St James' Hospital, Department of Histopathology, Dublin, Ireland
9St James's Hospital, Dublin, Ireland
10School of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, NC

Advaita Maria Dick, MSc1*, Erika Tsingos, Dr.2* and Baubak Bajoghli, Dr.3*

1University Hospital Tuebingen, Tuebingen, AL, Germany
2Leiden University, Leiden, Netherlands
3Department of Hematology, Oncology, Clinical Immunology, University Hospital Tuebingen, Tuebingen, Germany

*signifies non-member of ASH